{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:54:46Z","timestamp":1787842486959,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","award":["Project Number 11-W-00278\/6"],"award-info":[{"award-number":["Project Number 11-W-00278\/6"]}],"id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The Institute of Medicine reported that more than 1.5 million preventable adverse drug events occur annually in the United States. Comprehensive Medication Management (CMM) is the medication review process to improve clinical outcomes, enhance patient adherence, reduce drug therapy problems and reduce health care costs. University of Texas (UT) Physicians implemented a CMM program in several community-based clinics. We evaluated the effectiveness of CMM to reduce drug therapy problems and achieve medical cost savings.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a retrospective, observational study of CMM participants from October 2015 to September 2016. Program participants included patients aged 18\u2009years or older who had taken more than 4 prescribed medications and were diagnosed with at least one of the following chronic diseases: hypertension, congestive heart failure, chronic obstructive pulmonary disease, asthma or diabetes. Under the CMM program, a clinical pharmacist reviewed patients\u2019 electronic health records and created action plans to resolve identified drug problems. As part of the evaluation of the clinical process, two independent physicians conducted peer review on the recommendations issued by the pharmacist in order to establish inter-rater reliability of drug therapy problems and potential consequent medical services. The drug therapy problems were identified and classified into four categories: indication, effectiveness, safety and\/or compliance. The average cost of avoided medical services was obtained based on cost extrapolations from the literature, combined with hospital discharge data. Potential medical services avoided were linked to the average cost of those services to calculate the total cost savings of the program from the payers\u2019 perspective.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>By reviewing electronic health records of 3280 patients, the pharmacist identified 301 drug therapy problems and resolved 49.8% of these problems with collaboration from the patient\u2019s primary care physician or care team. The most commonly identified drug problems were related to potentially adverse drug reactions or inappropriate drug dosage. The CMM program resulted in potential cost savings of $1,143,015.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The CMM program resolved medication therapy problems among program participants and achieved significant health care cost savings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12913-020-05537-3","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T12:04:22Z","timestamp":1595246662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment program"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-1654","authenticated-orcid":false,"given":"Tong Han","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaelle","family":"Libaud-Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincy S.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Swint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio Juan","family":"Lansangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chi L.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"5537_CR1","first-page":"480","volume-title":"Preventing Medication Errors","author":"Institute of Medicine","year":"2007","unstructured":"Institute of Medicine. In: Aspden P, Wolcott J, Bootman JL, Cronenwett LR, editors. Preventing Medication Errors. Washington, DC: The National Academies Press; 2007. p. 480."},{"issue":"2","key":"5537_CR2","first-page":"192","volume":"41","author":"FR Ernst","year":"2001","unstructured":"Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192\u20139.","journal-title":"J Am Pharm Assoc"},{"key":"5537_CR3","volume-title":"The patient-centered medical home: integrating comprehensive medication management to optimize patient outcomes","author":"Patient-Centered Primary Care Collaborative","year":"2012","unstructured":"Patient-Centered Primary Care Collaborative. The patient-centered medical home: integrating comprehensive medication management to optimize patient outcomes. 2012."},{"issue":"4","key":"5537_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1377\/hlthaff.2011.0002","volume":"30","author":"M Smith","year":"2011","unstructured":"Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving patient medication management in primary care. Health Aff. 2011;30(4):646\u201354.","journal-title":"Health Aff"},{"issue":"11","key":"5537_CR5","first-page":"554","volume":"25","author":"LR Moczygemba","year":"2019","unstructured":"Moczygemba LR, Alshehri AM, Lawson K, Antoon D, McDaniel S, GJT M. Comprehensive health management pharmacist-delivered model: impact on healthcare utilization and costs. Am J Manag Care. 2019;25(11):554\u201360.","journal-title":"Am J Manag Care"},{"issue":"1","key":"5537_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.japh.2016.08.010","volume":"57","author":"MR de Bittner","year":"2017","unstructured":"de Bittner MR, Chirikov VV, Breunig IM, Zaghab RW, Shaya FT. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling. Am Pharm Assoc (2003). 2017;57(1):102\u20138 e4.","journal-title":"Am Pharm Assoc (2003)"},{"issue":"2","key":"5537_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.japh.2018.11.001","volume":"59","author":"PH Fabel","year":"2019","unstructured":"Fabel PH, Wagner T, Ziegler B, Fleming PA, Davis RE. A sustainable business model for comprehensive medication management in a patient-centered medical home. J Am Pharm Assoc (2003). 2019;59(2):285\u201390.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"34","key":"5537_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/phar.1438","volume":"8","author":"American College of Clinical Pharmacy","year":"2014","unstructured":"American College of Clinical Pharmacy. Standards of practice for clinical pharmacists. Pharmacotherapy. 2014;8(34):794\u20137.","journal-title":"Pharmacotherapy"},{"key":"5537_CR9","unstructured":"University of Minnesota College of Pharmacy. Pharmacotherapy workup Notes [cited 2019 February 26]. Available from: http:\/\/www.pharmacy.umn.edu\/pharmacotherapy-workup-notes."},{"issue":"15","key":"5537_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1001\/archinte.163.15.1813","volume":"163","author":"B Isetts","year":"2003","unstructured":"Isetts B, Brown L, Schondelmeyer S, Lenarz L. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163(15):1813\u201320.","journal-title":"Arch Intern Med"},{"key":"5537_CR11","unstructured":"Texas Health and Human Services Commission. Rate Analysis: Previous Inpatient and Outpatient Ratio of Cost to Charges (RCC Rates) [cited 2018 December 02]. Available from: https:\/\/rad.hhs.texas.gov\/hospitals-clinic\/previous-inpatient-and-outpatient-ratio-cost-charges-rcc-rates."},{"issue":"3","key":"5537_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18553\/jmcp.2010.16.3.185","volume":"16","author":"D Ramalho de Oliveira","year":"2010","unstructured":"Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185\u201395.","journal-title":"J Manag Care Pharm"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05537-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:17:25Z","timestamp":1626740245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05537-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5537"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05537-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at the University of Texas Health Science Center at Houston (HSC-MS-18-0936). As this study was retrospective in design, informed consent was not needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"671"}}